PR NEWS Logo
Home
PR NewsWire
NewsWire Today
MarketWire
Submit Your Feeds
Business News
•
MarketWire
• AtheroNova and Maxwell Biotech Group Agree on Deal Terms to Develop New Atherosclerosis Drug
AtheroNova and Maxwell Biotech Group Agree on Deal Terms to Develop New Atherosclerosis Drug
AtheroNova and Maxwell Biotech Group Agree on Deal Terms to Develop New Atherosclerosis Drug
Maxwell to Fund Clinical Trials, Become Equity Investor in AtheroNova, and License AHRO-001 for Russia
View More :
http://www.marketwire.com/mw/release.do?id=1558758&sourceType=3
Releted News by marketwire
AtheroNova and Maxwell Biotech Group Agree on Deal Terms to Develop New Atherosclerosis Drug
Paul Louie Joins Cascadia Capital as Managing Director of the Middle Markets Practice Group
IIROC; Resumption; Primero Mining Corp.